GlassScriptPhysician profile
Pavan Atluri
NPI 1407913940
$164,946.69
in general payments reported to CMS, 2019-2025
13 companies · $36K in 2025
The $36K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $8,407 · 2021: $1,125 · 2022: $21K · 2023: $28K · 2024: $52K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $84K · Travel and Lodging: $23K · Food and Beverage: $6,062 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $83,806.25 |
| Travel and Lodging | $23,488.49 |
| Food and Beverage | $6,061.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $123,347.93 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Mitris Resilia Mitral Valve, Evoque |
| Medtronic, INC. | $15,265.41 | 2021-2024 | Corevalve Evolut R, Avalus |
| Abbott Laboratories | $14,627.20 | 2019-2025 | Tendyne, Mitraclip, Navitor |
| Medtronic Vascular, INC. | $9,747.32 | 2019-2020 | |
| Atricure, INC. | $1,441.16 | 2019-2025 | Synergy Ablation System |
| Baxter Healthcare | $94.10 | 2024 | Floseal |
| Getinge USA Sales, LLC | $89.40 | 2023 | Cardioroot |
| Paladin Technology Solutions | $79.63 | 2025 | |
| Xvivo Perfusion INC. | $76.67 | 2022 | |
| Paragonix Technologies, INC. | $76.11 | 2019 | |
| Artivion, INC. | $46.57 | 2019 | |
| Boston Scientific Corporation | $40.11 | 2022 | |
| Smith+Nephew, INC. | $15.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pavan Atluri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.